Farletuzumab ecteribulin, CAS [[2407465-18-1]]

Produktübersicht

• Artikelname: Farletuzumab ecteribulin, CAS [[2407465-18-1]]
• Artikelnummer: TGM-T77908
• Hersteller Artikelnummer: T77908
• Alternativnummer: TGM-T77908-1MG,TGM-T77908-5MG,TGM-T77908-10MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: MORAb202 , MORAb-202 , MORAb 202

Produktbeschreibung

Farletuzumab ecteribulin is an antibody-drug conjugate (ADC) consisting of the humanized antibody farletuzumab, which targets the folate receptor alpha (FRA), with an antibody-to-drug ratio of 4.0. In vitro, farletuzumab ecteribulin exhibits cytotoxic and antitumor activity against FRA-positive cells.

Produkteigenschaften

• CAS Nummer: [2407465-18-1]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs)